ライフサイエンスコーパス: Klebsiella pneumonia

1 , Proteus mirabilis, Pseudomonas aeruginosa, Klebsiella pneumonia.

2 his study; 4 control mice and 6 administered Klebsiella pneumonia.

3 reptococcus agalactiae, Escherichia coli and Klebsiella pneumonia.

4 role for leptin in the host defense against Klebsiella pneumonia.

5 nt immunoadjuvant in the treatment of murine Klebsiella pneumonia.

6 tial cytokine mediator of innate immunity in Klebsiella pneumonia.

7 between L-NAME- and D-NAME-treated mice with Klebsiella pneumonia.

8 nflux and lung bacterial clearance in murine Klebsiella pneumonia.

9 t late (after 72 h) survival in animals with Klebsiella pneumonia.

10 r IL-12 to the lung in the setting of murine Klebsiella pneumonia.

11 nent of antibacterial host defense in murine Klebsiella pneumonia.

12 nflux and lung bacterial clearance in murine Klebsiella pneumonia.

13 Murine acute pneumonia model induced by Klebsiella pneumonia.

14 , including members from the human pathogens Klebsiella pneumonia and Enterobacter aerogenes, and wou

15 , Salmonella Paratyphi B, Shigella flexneri, Klebsiella pneumonia and Escherichia coli, therefore dis

16 tudy indicates that MIP-2 is produced during Klebsiella pneumonia and inhibition of MIP-2 bioactivity

17 MIP-2 is produced during Klebsiella pneumonia and inhibition of MIP-2 bioactivity

18 ed sample revealed multidrug resistant (MDR) Klebsiella pneumonia and the strain was found to be sens

19 entalized IL-12 overexpression on outcome in Klebsiella pneumonia, animals were treated i.t. with 5 x

20 This study uses Klebsiella pneumonia as a model organism because it elic

21 1 is important for local host defense during Klebsiella pneumonia by maintaining adequate AM numbers

22 enhanced rather than decreased lethality of Klebsiella pneumonia compared to that for animals receiv

23 defenses during lethal pneumonia induced by Klebsiella pneumonia, compared to wild-type mice.

24 protected during lethal pneumonia induced by Klebsiella pneumonia, compared to wild-type mice.

25 olar lavage fluid from A(2B)R(-/-) mice with Klebsiella pneumonia contained more extracellular DNA co

26 unds show activity against Escherichia coli, Klebsiella pneumonia, Enterobacter cloacae, Acinetobacte

27 Gram-negative bacteria Escherichia coli and Klebsiella pneumonia following BCG vaccination, but no e

28 tion between CIP@TiO(2)NPs nanoparticles and Klebsiella pneumonia (ID: 8JGW) was studied using 50 con

29 Here, we identify Klebsiella pneumonia in the microbiota of patients with

30 t innate immune response to LPS stimulation, Klebsiella pneumonia infection or Mycobacterium tubercul

31 Klebsiella pneumonia infection rates have increased dram

32 Lungkine null mice were more susceptible to Klebsiella pneumonia infection, with a decreased surviva

33 is are powerful tools that can shed light on Klebsiella pneumonia infections.

34 ecFabB homologues in Serratia marcescens and Klebsiella pneumonia is an important factor for the in v

35 The pathogenesis of Klebsiella pneumonia is linked to the bacteria's ability

36 ells following immunization with heat-killed Klebsiella pneumonia (Kp).

37 beta-lactamase-producing Escherichia coli or Klebsiella pneumonia, methicillin-resistant Staphylococc

38 To assess the role of NO in Klebsiella pneumonia, mice were treated intraperitoneall

39 ection, as shown by increased mortality in a Klebsiella pneumonia model.

40 say for DNA specific to antibiotic-resistant Klebsiella pneumonia on the road.

41 lebsiella pneumonia, whereas no animals with Klebsiella pneumonia receiving control adenovirus surviv

42 res of Escherichia coli, Vibrio cholera, and Klebsiella pneumonia SlmA-DNA-FtsZ CTD ternary complexes

43 This study focuses on isolate Klebsiella pneumonia SSN1, Klebsiella quasipeumonniae SG

44 ophthalmitis in this investigation and found Klebsiella pneumonia to be the causative organism among

45 mIL-12 resulted in 45% long term survival in Klebsiella pneumonia, whereas no animals with Klebsiella